Torley Helen

Torley Helen, PRESIDENT AND CEO, Director, has filed 14 insider trading reports covering 1 company. Total disclosed trading volume is $50.2M. Sales ($31.8M) outpace purchases ($0) over this period. Insider sales are common for diversification and personal financial planning and should be evaluated with full context. The largest single filing involves HALOZYME THERAPEUTICS, INC. (HALO). All transactions sourced from SEC Form 4 filings.